Analytical and clinical sensitivity of West Nile virus RNA screening and supplemental assays available in 2003

Transfusion

Volumn 45, Issue 4, 2005, Pages 492-499

  Busch, Michael P ^a   Tobler, L H ^b   Saldanha, J ^b   Caglioti, S ^b   Shyamala, V ^b   Linnen, J M ^b   Gallarda, J ^b   Phelps, B ^b   Smith, R I F ^b   Drebot, M ^b   Kleinman, S H ^b  

^a BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CONTROLLED STUDY; DILUTION; EPIDEMIC; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; NUCLEIC ACID AMPLIFICATION; RNA ANALYSIS; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; VIREMIA; VIRUS LOAD; VIRUS TRANSMISSION; WEST NILE FLAVIVIRUS;

BLOOD BANKS; CANADA; HUMANS; MASS SCREENING; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; UNITED STATES; VIRAL LOAD; VIREMIA; WEST NILE FEVER; WEST NILE VIRUS;

EID: 20144387769     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0041-1132.2005.04382.x     Document Type: Article

References (16)

1. Petersen LR, Marfin AA, Gubler DJ. West Nile virus. JAMA 2003;290:524-8.
2. Centers for Disease Control and Prevention. Provisional surveillance summary of the West Nile virus epidemic - United States, January-November 2002. JAMA 2003;289:293-4.
3. Pealer LN, Martin AA, Petersen LR, et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med 2003;349:1236-45.
4. Iwamoto M, Jernigan DB, Guasch A, et al. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med 2003;348:2196-203.
5. Stramer SL, Glynn SA, Kleinman SH, et al. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid amplification testing. N Engl J Med 2004;351:760-8.
6. Grant PR, Busch MP. Nucleic acid amplification technology methods used in blood donor screening [review]. Transfus Med 2002;12:229-42.
7. Dodd RY. Emerging infections, transfusion safety, and epidemiology. N Engl J Med 2003;349:1205-6.
8. Centers for Disease Control and Prevention (CDC). Update. West Nile virus screening of blood donations and transfusion-associated transmission - United States, 2003. MMWR Morb Mortal Wkly Rep 2004;53:281-4.
9. Caglioti S, McAuley J, Robertson GF, et al. Yield of West Nile virus RNA screening of U.S. blood donors [11-abstract book part 1]. Blood 2003;102:57a.
10. Tobler LH, Bianco C, Glynn SA, et al. Detection of West Nile virus RNA and antibody in frozen plasma components from a voluntary market withdrawal during the 2002 peak epidemic. Transfusion 2005;45:480-6.
11. Saldanha J, Shead S, Heath A, Drebot M, West Nile Virus Collaborative Study Group. Collaborative study to evaluate a working reagent for West Nile Virus (WNV) RNA detection by NAT. Transfusion 2005;45:97-102.
12. Macedo de Oliveira A, Beecham B, Lanciotti R, et al. West Nile virus blood transfusion-related infection despite nucleic acid testing. Transfusion 2004;44:1695-9.
13. Francis B, Green M, Payne C, eds. The GLIM system: release 4 manual. Oxford: Oxford Science Publications, Clarendon Press; 1993.
14. Biswas R, Tabor E, Hsia CC, et al. Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. Transfusion 2003;43:788-98.
15. Diamond MS, Sitati EM, Friend LD, et al. A critical role for induced IgM in the protection against West Nile virus infection. J Exp Med 2003;198:1853-62.
16. Custer BS, Tomasulo PA, Murphy EL, et al. Triggers for switching from minipool testing by nucleic acid technology to individual donation nucleic acid testing for West Nile virus: analysis of 2003 data to inform 2004 decision making. Transfusion 2004;44:1547-54.